Mortality after hospital discharge among children younger than 5 years admitted with suspected sepsis in Uganda: a prospective, multisite, observational cohort study.


Journal

The Lancet. Child & adolescent health
ISSN: 2352-4650
Titre abrégé: Lancet Child Adolesc Health
Pays: England
ID NLM: 101712925

Informations de publication

Date de publication:
08 2023
Historique:
received: 20 12 2022
revised: 24 02 2023
accepted: 01 03 2023
pmc-release: 01 08 2024
medline: 4 10 2023
pubmed: 15 5 2023
entrez: 14 5 2023
Statut: ppublish

Résumé

Substantial mortality occurs after hospital discharge in children younger than 5 years with suspected sepsis, especially in low-income countries. A better understanding of its epidemiology is needed for effective interventions to reduce child mortality in these countries. We evaluated risk factors for death after discharge in children admitted to hospital for suspected sepsis in Uganda, and assessed how these differed by age, time of death, and location of death. In this prospective, multisite, observational cohort study, we recruited and consecutively enrolled children aged 0-60 months admitted with suspected sepsis from the community to the paediatric wards of six Ugandan hospitals. Suspected sepsis was defined as the need for admission due to a suspected or proven infectious illness. At admission, trained study nurses systematically collected data on clinical variables, sociodemographic variables, and baseline characteristics with encrypted study tablets. Participants were followed up for 6 months after discharge by field officers who contacted caregivers at 2 months and 4 months after discharge by telephone and at 6 months after discharge in person to measure vital status, health-care seeking after discharge, and readmission details. We assessed 6-month mortality after hospital discharge among those discharged alive, with verbal autopsies conducted for children who had died after hospital discharge. Between July 13, 2017, and March 30, 2020, 16 991 children were screened for eligibility. 6545 children (2927 [44·72%] female children and 3618 [55·28%] male children) were enrolled and 6191 were discharged from hospital alive. 6073 children (2687 [44·2%] female children and 3386 [55·8%] male children) completed follow-up. 366 children died in the 6-month period after discharge (weighted mortality rate 5·5%). Median time from discharge to death was 28 days (IQR 9-74). For the 360 children for whom location of death was documented, deaths occurred at home (162 [45·0%]), in transit to care (66 [18·3%]), or in hospital (132 [36·7%]) during a subsequent readmission. Death after hospital discharge was strongly associated with weight-for-age Z scores less than -3 (adjusted risk ratio [aRR] 4·7, 95% CI 3·7-5·8 vs a Z score of >-2), discharge or referral to a higher level of care (7·3, 5·6-9·5), and unplanned discharge (3·2, 2·5-4·0). Hazard ratios (HRs) for severe anaemia (<7g/dL) increased with time since discharge, from 1·7 (95% CI 0·9-3·0) for death occurring in the first time tertile to 5·2 (3·1-8·5) in the third time tertile. HRs for some discharge vulnerabilities decreased significantly with increasing time since discharge, including unplanned discharge (from 4.5 [2·9-6·9] in the first tertile to 2·0 [1·3-3·2] in the third tertile) and poor feeding status (from 7·7 [5·4-11·0] to 1·84 [1·0-3·3]). Age interacted with several variables, including reduced weight-for-age Z score, severe anaemia, and reduced admission temperature. Paediatric mortality following hospital discharge after suspected sepsis is common, with diminishing, although persistent, risk during the first 6 months after discharge. Efforts to improve outcomes after hospital discharge are crucial to achieving Sustainable Development Goal 3.2 (ending preventable childhood deaths under age 5 years). Grand Challenges Canada, Thrasher Research Fund, BC Children's Hospital Foundation, and Mining4Life.

Sections du résumé

BACKGROUND
Substantial mortality occurs after hospital discharge in children younger than 5 years with suspected sepsis, especially in low-income countries. A better understanding of its epidemiology is needed for effective interventions to reduce child mortality in these countries. We evaluated risk factors for death after discharge in children admitted to hospital for suspected sepsis in Uganda, and assessed how these differed by age, time of death, and location of death.
METHODS
In this prospective, multisite, observational cohort study, we recruited and consecutively enrolled children aged 0-60 months admitted with suspected sepsis from the community to the paediatric wards of six Ugandan hospitals. Suspected sepsis was defined as the need for admission due to a suspected or proven infectious illness. At admission, trained study nurses systematically collected data on clinical variables, sociodemographic variables, and baseline characteristics with encrypted study tablets. Participants were followed up for 6 months after discharge by field officers who contacted caregivers at 2 months and 4 months after discharge by telephone and at 6 months after discharge in person to measure vital status, health-care seeking after discharge, and readmission details. We assessed 6-month mortality after hospital discharge among those discharged alive, with verbal autopsies conducted for children who had died after hospital discharge.
FINDINGS
Between July 13, 2017, and March 30, 2020, 16 991 children were screened for eligibility. 6545 children (2927 [44·72%] female children and 3618 [55·28%] male children) were enrolled and 6191 were discharged from hospital alive. 6073 children (2687 [44·2%] female children and 3386 [55·8%] male children) completed follow-up. 366 children died in the 6-month period after discharge (weighted mortality rate 5·5%). Median time from discharge to death was 28 days (IQR 9-74). For the 360 children for whom location of death was documented, deaths occurred at home (162 [45·0%]), in transit to care (66 [18·3%]), or in hospital (132 [36·7%]) during a subsequent readmission. Death after hospital discharge was strongly associated with weight-for-age Z scores less than -3 (adjusted risk ratio [aRR] 4·7, 95% CI 3·7-5·8 vs a Z score of >-2), discharge or referral to a higher level of care (7·3, 5·6-9·5), and unplanned discharge (3·2, 2·5-4·0). Hazard ratios (HRs) for severe anaemia (<7g/dL) increased with time since discharge, from 1·7 (95% CI 0·9-3·0) for death occurring in the first time tertile to 5·2 (3·1-8·5) in the third time tertile. HRs for some discharge vulnerabilities decreased significantly with increasing time since discharge, including unplanned discharge (from 4.5 [2·9-6·9] in the first tertile to 2·0 [1·3-3·2] in the third tertile) and poor feeding status (from 7·7 [5·4-11·0] to 1·84 [1·0-3·3]). Age interacted with several variables, including reduced weight-for-age Z score, severe anaemia, and reduced admission temperature.
INTERPRETATION
Paediatric mortality following hospital discharge after suspected sepsis is common, with diminishing, although persistent, risk during the first 6 months after discharge. Efforts to improve outcomes after hospital discharge are crucial to achieving Sustainable Development Goal 3.2 (ending preventable childhood deaths under age 5 years).
FUNDING
Grand Challenges Canada, Thrasher Research Fund, BC Children's Hospital Foundation, and Mining4Life.

Identifiants

pubmed: 37182535
pii: S2352-4642(23)00052-4
doi: 10.1016/S2352-4642(23)00052-4
pmc: PMC10543357
mid: NIHMS1908698
pii:
doi:

Types de publication

Observational Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

555-566

Subventions

Organisme : NIEHS NIH HHS
ID : K23 ES030399
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests We declare no competing interests.

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Pediatr Crit Care Med. 2016 May;17(5):400-5
pubmed: 27043996
Lancet Glob Health. 2022 May;10(5):e673-e684
pubmed: 35427524
Multivariate Behav Res. 2016 Jul-Aug;51(4):495-518
pubmed: 27269278
Afr Health Sci. 2016 Dec;16(4):883-891
pubmed: 28479878
JAMA Netw Open. 2019 Jan 4;2(1):e187387
pubmed: 30681712
Pediatr Crit Care Med. 2005 Jan;6(1):2-8
pubmed: 15636651
PLoS One. 2013 Jun 25;8(6):e66698
pubmed: 23825556
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
PLoS One. 2019 Jun 20;14(6):e0214563
pubmed: 31220109
JAMA Pediatr. 2018 Mar 1;172(3):213-214
pubmed: 29379956
Transl Pediatr. 2021 Oct;10(10):2666-2677
pubmed: 34765492
Immunol Rev. 2016 Nov;274(1):330-353
pubmed: 27782333
Lancet Glob Health. 2019 Oct;7(10):e1435-e1447
pubmed: 31537373
Lancet Child Adolesc Health. 2022 Jul;6(7):474-483
pubmed: 35605629
Lancet Glob Health. 2022 Feb;10(2):e195-e206
pubmed: 35063111
EBioMedicine. 2020 Nov;61:103044
pubmed: 33039713
Pediatrics. 2019 Jan;143(1):
pubmed: 30552144
BMJ Open. 2018 Dec 28;8(12):e023445
pubmed: 30593550
Wellcome Open Res. 2020 Oct 8;5:234
pubmed: 33195820
Lancet Child Adolesc Health. 2023 Mar;7(3):149-151
pubmed: 36682368
N Engl J Med. 2020 Dec 3;383(23):2242-2254
pubmed: 33264546
Int J Equity Health. 2020 Aug 10;19(1):136
pubmed: 32778121
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Lancet. 2020 Jan 18;395(10219):200-211
pubmed: 31954465
Emerg Themes Epidemiol. 2021 Mar 18;18(1):4
pubmed: 33736661
Lancet Glob Health. 2018 Jun;6(6):e691-e702
pubmed: 29773123
PLoS One. 2018 Aug 14;13(8):e0202334
pubmed: 30106987

Auteurs

Matthew O Wiens (MO)

Centre for International Child Health, BC Children's Hospital, Vancouver, BC, Canada; BC Children's Hospital Research Institute, BC Children's Hospital, Vancouver, BC, Canada; Department of Anesthesiology, Pharmacology, and Therapeutics, University of British Columbia, Vancouver, BC, Canada; Walimu, Kampala, Uganda. Electronic address: matthew.wiens@bcchr.ca.

Jeffrey N Bone (JN)

Centre for International Child Health, BC Children's Hospital, Vancouver, BC, Canada; BC Children's Hospital Research Institute, BC Children's Hospital, Vancouver, BC, Canada.

Elias Kumbakumba (E)

Department of Paediatrics and Child Health, Mbarara University of Science and Technology, Mbarara, Uganda.

Stephen Businge (S)

Holy Innocents Children's Hospital, Mbarara, Uganda.

Abner Tagoola (A)

Department of Paediatrics, Jinja Regional Referral Hospital, Jinja City, Uganda.

Sheila Oyella Sherine (SO)

Department of Paediatrics, Masaka Regional Referral Hospital, Masaka, Uganda.

Emmanuel Byaruhanga (E)

Kawempe National Referral Hospital, Kampala, Uganda.

Edward Ssemwanga (E)

Villa Maria Hospital, Masaka, Uganda.

Celestine Barigye (C)

Mbarara Regional Referral Hospital, Mbarara, Uganda.

Jesca Nsungwa (J)

Ministry of Health for the Republic of Uganda, Kampala, Uganda.

Charles Olaro (C)

Ministry of Health for the Republic of Uganda, Kampala, Uganda.

J Mark Ansermino (JM)

Centre for International Child Health, BC Children's Hospital, Vancouver, BC, Canada; BC Children's Hospital Research Institute, BC Children's Hospital, Vancouver, BC, Canada; Department of Anesthesiology, Pharmacology, and Therapeutics, University of British Columbia, Vancouver, BC, Canada.

Niranjan Kissoon (N)

BC Children's Hospital Research Institute, BC Children's Hospital, Vancouver, BC, Canada; Department of Paediatrics, University of British Columbia, Vancouver, BC, Canada.

Joel Singer (J)

School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.

Charles P Larson (CP)

School of Population and Global Health, McGill University, Montreal, QC, Canada.

Pascal M Lavoie (PM)

BC Children's Hospital Research Institute, BC Children's Hospital, Vancouver, BC, Canada; Department of Paediatrics, University of British Columbia, Vancouver, BC, Canada.

Dustin Dunsmuir (D)

Centre for International Child Health, BC Children's Hospital, Vancouver, BC, Canada; BC Children's Hospital Research Institute, BC Children's Hospital, Vancouver, BC, Canada.

Peter P Moschovis (PP)

Division of Global Health, Massachusetts General Hospital, Boston, MA, USA.

Stefanie Novakowski (S)

Centre for International Child Health, BC Children's Hospital, Vancouver, BC, Canada; Department of Anesthesiology, Pharmacology, and Therapeutics, University of British Columbia, Vancouver, BC, Canada.

Clare Komugisha (C)

Walimu, Kampala, Uganda.

Mellon Tayebwa (M)

Walimu, Kampala, Uganda.

Douglas Mwesigwa (D)

Walimu, Kampala, Uganda.

Cherri Zhang (C)

Centre for International Child Health, BC Children's Hospital, Vancouver, BC, Canada.

Martina Knappett (M)

Centre for International Child Health, BC Children's Hospital, Vancouver, BC, Canada.

Nicholas West (N)

BC Children's Hospital Research Institute, BC Children's Hospital, Vancouver, BC, Canada.

Vuong Nguyen (V)

Centre for International Child Health, BC Children's Hospital, Vancouver, BC, Canada.

Nathan Kenya Mugisha (NK)

Walimu, Kampala, Uganda.

Jerome Kabakyenga (J)

Maternal Newborn and Child Health Institute, Mbarara University of Science and Technology, Mbarara, Uganda; Department of Community Health, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH